VEGFR-2-IN-39 is a PROTAC designed to specifically target VEGFR-2, exhibiting low toxicity. This compound effectively inhibits the proliferation of EA.hy926 cells, a line derived from human umbilical vein endothelial cells, in a concentration-dependent manner. Its structural composition enables effective interaction with VEGFR-2, making it useful for studying vascular-related pathways.
Usually ships within 24 hours.